We are live on ! Find out more
Dodge & Cox

Dodge & Cox Portfolio holdings

AUM $191B
1-Year Est. Return 17.5%
 

Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.

This Fund
S&P 500
This Quarter Est. Return
+12.24%
1 Year Est. Return
+17.5%
3 Year Est. Return
+69.9%
5 Year Est. Return
+90.48%
10 Year Est. Return
+363.57%
AUM
$95.9B
AUM Growth
+$7.89B
Cap. Flow
-$2.04B
Cap. Flow %
-2.12%
Top 10 Hldgs %
34.91%
Holding
167
New
3
Increased
19
Reduced
96
Closed
4

Top Sells

Rank Stock Value
1
MOLXA
MOLEX INC CL-A
MOLXA
+$680M
2
DOX icon
Amdocs
DOX
+$501M
3
DD icon
DuPont de Nemours
DD
+$468M
4
FDX icon
FedEx
FDX
+$443M
5
GNW icon
Genworth Financial
GNW
+$414M

Sector Composition

Rank Sector Weight
1 Financials 20.99%
2 Technology 20.48%
3 Healthcare 18.33%
4 Communication Services 15.59%
5 Energy 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
151
Mondelez International
MDLZ
$79.7B
$418K ﹤0.01%
11,840
AET
152
DELISTED
Aetna Inc
AET
$412K ﹤0.01%
6,000
AGN
153
DELISTED
Allergan Inc
AGN
$396K ﹤0.01%
3,564
PSX icon
154
Phillips 66
PSX
$95.7B
$355K ﹤0.01%
4,600
-500
-10% -$33.4K
WBA
155
DELISTED
Walgreens Boots Alliance
WBA
$349K ﹤0.01%
6,069
MCO icon
156
Moody's
MCO
$88.2B
$337K ﹤0.01%
4,300
ELV icon
157
Elevance Health
ELV
$86.6B
$277K ﹤0.01%
3,000
VZ icon
158
Verizon
VZ
$205B
$270K ﹤0.01%
5,500
-700
-11% -$34.4K
ALL icon
159
Allstate
ALL
$65.1B
$258K ﹤0.01%
4,724
PCG icon
160
PG&E
PCG
$39.5B
$257K ﹤0.01%
6,382
BAX icon
161
Baxter International
BAX
$13.4B
$235K ﹤0.01%
6,226
ADP icon
162
Automatic Data Processing
ADP
$113B
$220K ﹤0.01%
+3,098
New +$208K
KRFT
163
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$213K ﹤0.01%
3,946
GNW icon
164
Genworth Financial
GNW
$3.75B
-32,373,141
Closed -$414M
RTX icon
165
RTX Corp
RTX
$286B
-3,006
Closed -$204K
MOLX
166
DELISTED
MOLEX INC
MOLX
-2,712,027
Closed -$104M
MOLXA
167
DELISTED
MOLEX INC CL-A
MOLXA
-17,754,019
Closed -$680M

Similar funds

Dodge & Cox's Q4 2013 Portfolio in Review

As of Q4 2013, Dodge & Cox held 167 positions worth $95.9B, up 9% from $88B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 4.2%. Dodge & Cox opened 3 new positions and exited 4, leaving the 167-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

  • Dodge & Cox's largest Q4 2013 buy was Express Scripts Holding Company: 5,609,705 shares worth $394M.
  • Dodge & Cox added most to Gen Digital in Q4 2013, an estimated $395M increase.
  • Dodge & Cox's biggest Q4 2013 reduction was Amdocs, cutting an estimated $501M.
  • Dodge & Cox fully exited MOLEX INC CL-A in Q4 2013, selling an estimated $680M.
  • Dodge & Cox's ten largest holdings make up 35% of its $95.9B portfolio in Q4 2013.
  • Dodge & Cox opened 3 new positions and closed 4 in Q4 2013.
  • Dodge & Cox's portfolio value rose 9% quarter-over-quarter to $95.9B.

Based on Dodge & Cox's 13F filing for Q4 2013, filed 14 Feb 2014.